160 related articles for article (PubMed ID: 26393826)
1. Naloxegol (Movantik) for opioid-induced constipation.
Med Lett Drugs Ther; 2015 Sep; 57(1478):135-7. PubMed ID: 26393826
[No Abstract] [Full Text] [Related]
2. ▼Naloxegol for opioid-induced constipation.
Drug Ther Bull; 2015 Dec; 53(12):138-40. PubMed ID: 26660436
[TBL] [Abstract][Full Text] [Related]
3. Naloxegol oxalate, pirfenidone, and nintedanib.
Hussar DA; Jeon MM
J Am Pharm Assoc (2003); 2015; 55(4):461-3. PubMed ID: 26161491
[No Abstract] [Full Text] [Related]
4. Naloxegol for the treatment of opioid-induced constipation.
Tack J; Corsetti M
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
[TBL] [Abstract][Full Text] [Related]
5. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
Jones R; Prommer E; Backstedt D
Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
[TBL] [Abstract][Full Text] [Related]
6. Naloxegol: a review of its use in patients with opioid-induced constipation.
Garnock-Jones KP
Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
White WB; Kowey P; Diva U; Sostek M; Tummala R
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
[TBL] [Abstract][Full Text] [Related]
8. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
Corsetti M; Tack J
Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
[TBL] [Abstract][Full Text] [Related]
9. A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation.
Webster L; Tummala R; Diva U; Lappalainen J
J Opioid Manag; 2016; 12(6):405-419. PubMed ID: 28059433
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
[TBL] [Abstract][Full Text] [Related]
11. Naloxegol for managing opioid-induced constipation.
Shelton KN; Clements JN
JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
[TBL] [Abstract][Full Text] [Related]
12. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
13. Opioid-Induced Constipation Part 2: Newer Therapies #295.
Badke A; Rosielle DA
J Palliat Med; 2015 Oct; 18(10):893-4. PubMed ID: 26439728
[No Abstract] [Full Text] [Related]
14. Treating Opioid-Induced Constipation in Older Adults: New Options.
Sani H; Mahan RJ
Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
[TBL] [Abstract][Full Text] [Related]
15. Pharmacometric Modeling of Naloxegol Efficacy and Safety: Impact on Dose and Label.
Al-Huniti N; Zhou D; Xu H; Aksenov S; Bui KH; Fox R; Helmlinger G; Stanski D
Clin Pharmacol Ther; 2017 Nov; 102(5):741-744. PubMed ID: 28548207
[TBL] [Abstract][Full Text] [Related]
16. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.
Gálvez R; Maire C; Tovar I; Vargas P
A A Pract; 2018 Jul; 11(1):22-24. PubMed ID: 29634552
[TBL] [Abstract][Full Text] [Related]
17. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
Lawson R; King F; Marsh K; Altincatal A; Cimen A
Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
[TBL] [Abstract][Full Text] [Related]
18. Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation.
Al-Huniti N; Nielsen JC; Hutmacher MM; Lappalainen J; Cantagallo K; Sostek M
CPT Pharmacometrics Syst Pharmacol; 2016 Jul; 5(7):359-66. PubMed ID: 27435972
[TBL] [Abstract][Full Text] [Related]
19. Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.
Leonard J; Baker DE
Ann Pharmacother; 2015 Mar; 49(3):360-5. PubMed ID: 25471070
[TBL] [Abstract][Full Text] [Related]
20. Naloxegol for opioid-induced constipation in patients with noncancer pain.
Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
